CD274 and cancer: To this aim, we first tested the effects on cancer cell viability of the anti-EGFR CL4 aptamer in combination with a human anti-PD-L1 mAb named 10_12 [55] to then verify whether a bispecific construct made up of these two moieties could be considered beneficial for anti-cancer treatment.